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Abstract.  The type H membrane protein p63 is a resi- 
dent protein of a membrane network interposed be- 
tween rough ER and Golgi apparatus.  To study the 
retention of p63, mutant forms were expressed in COS 
cells and the intracellular  distribution determined by 
immunofluorescence microscopy. Investigation of chi- 
meric constructs between p63 and the plasma mem- 
brane protein dipeptidylpeptidase IV showed that pro- 
tein sequences from all three domains of the p63 
protein are required  to achieve complete intracellular 
retention.  Mutational analysis of the 106-amino acid 
cytoplasmic tail of p63 revealed that the NH2-terminal 
23 amino acids are necessary for retention.  When Igi3 
was solubilized with Triton X-100 and subjected to 
centrifugation at 100,000 g,  it formed large,  insoluble 
oligomers, particularly at neutral pH and below. A 
comparison of the behavior of wildtype and mutant 
p63 proteins in this assay revealed a perfect correla- 
tion between the formation of large oligomers and cor- 
rect intracellular retention.  These results suggest that 
self-association may be a major mechanism by which 
p63 is retained between the rough ER and the Golgi 
apparatus. 
T 
HE Secretory pathway of eukaryotic cells is composed 
of a series of different compartments through  which 
newly synthesized proteins are transported en route to 
their final destination  in the cell (Paiade,  1975). Each of the 
subcellular organelles  along this pathway contains a charac- 
teristic set of  proteins that maintain their structural and func- 
tionai integrity. A challenging question in contemporary cell 
biology is to understand how resident components,  unlike 
itinerant proteins,  achieve specific localization  in a given in- 
tracellular compartment. 
It is currently believed that secretory proteins are trans- 
ported by a default pathway while resident proteins are selec- 
tively retained in individual  organelles  by means of specific 
signals  (Pfeffer and Rothman,  1987; Wieland  et al.,  1987; 
Karrenbauer et al., 1990). Two types of signais, which medi- 
ate either the retention or the retrieval of proteins,  have been 
identified to date.  A variety of lumenal  ER proteins are re- 
tained in the cell by means of a COOH-terminal tetrapeptide 
(KDEL) or related  sequence (Munro  and  Pelham,  1987; 
reviewed by Pelham,  1989, 1990) that allows retrievai of the 
proteins from a post-ER site by means of KDEL receptors 
(Lewis and Pelham,  1990,  1992). A group of type I trans- 
membrane proteins of the ER are also retained in this or- 
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ganelle  by a  retrieval  mechanism  (Jackson  et al.,  1993). 
These proteins contain cytoplasmic sequences consisting  of 
two lysine residues positioned three and four or five residues 
from the COOH terminus (KKXX or KXKXX, where X can 
be almost any amino acid) (Jackson et ai., 1990; Shin et ai., 
1991). Recycling of these proteins is believed to occur from 
multiple  post-ER  locations  along  the  secretory  pathway 
(Jackson  et ai.,  1993). In addition,  retrieval  has been sug- 
gested to be the mechanism by which the integral membrane 
protein TGN38 is targeted to the TGN (Bos et ai.,  1993; 
Humphrey et al.,  1993).  TGN38 possesses a tyrosine-con- 
taining  motif within its cytoplasmic tail that is both neces- 
sary and sufficient for TGN localization  (Bos et ai.,  1993; 
Humphrey et ai., 1993; Wong and Hong, 1993). In contrast 
to these examples, localization  of Golgi proteins is achieved 
by retention  rather than  retrieval.  The retention of several 
Golgi proteins has been shown to depend primarily on their 
single transmembrane segment with some additional contri- 
bution to retention  by the sequences just adjacent to those 
membrane anchors  (Nilsson et ai., 1991; Swift and Macha- 
mer,  1991; Machamer et al.,  1993).  In the case of the c~ 
2,6-siaiyltransferase, the cytoplasmic and lumenal sequences 
flanking the transmembrane segment appear to be the crucial 
elements for retention  rather than the transmembrane seg- 
ment itself (Munro,  1991; Dahdal and Colley,  1993). It has 
been postulated that resident Golgi proteins oligomerize in 
the Golgi apparatus  upon recognition  of identical or related 
© The Rockefeller University Press, 0021-9525/94/07/25/15 $2.00 
The Journal of Cell Biology, Volume 126, Number 1, July 1994 25-39  25 proteins,  forming a complex of sufficient size to prevent en- 
try into transport vesicles (Machamer,  1991; Nilsson et al., 
1991, 1993, 1994). Recently, oligomerization  of a chimeric 
protein containing  the first membrane-spanning  domain of 
the M glycoprotein of avian coronavirus  has been correlated 
to its retention  in the Golgi apparatus  (Weisz et al.,  1993). 
In  contrast  to the considerable progress that  has  been 
made in understanding  protein localization in the ER and the 
Golgi apparatus,  it is presently unclear  how the recently 
identified  ER-Golgi  intermediate  compartment  (ERGIC) 1 
maintains its resident population of  proteins (for a review see 
Hauri and Schweizer, 1992). The ERGIC comprises a mem- 
brane system interposed between the rough ER and the cis 
side of the Golgi apparatus  that has been shown to mediate 
ER-to-Golgi  exocytic  protein transport  (Schweizer  et al., 
1990; Lotti et al., 1992). The ERGIC may correspond to the 
"budding compartment"  of mouse coronavirus (Tooze et al., 
1988;  Krijnse-Locker et al.,  1994) and to the "pre-Golgi 
vacuoles" of Semliki Forest virus-infected cells (Saraste and 
Kuismanen,  1984). Isolation  of the ERGIC from Vero cells 
indicated that this compartment has unique properties since 
it  does  not  share  major  marker  proteins  with  its  direct 
neighbor organelles,  the rough ER and cis-Golgi apparatus 
(Schweizer  et al.,  1991). Currently,  a  limited  number of 
marker proteins are available for the ERGIC.  The ERGIC 
was originally defined by a 53-kD type I transmembrane pro- 
tein (Schweizer et al., 1988) termed ERGIC-53.  ERGIC-53 
is specifically  localized  in the ERGIC at 37°C but under- 
goes  a  temperature-dependent  redistribution  (Lippincott- 
Schwartz  et al.,  1990;  Schweizer  et al.,  1990) which sug- 
gested that  it may follow a  recycling  pathway  (Hauri and 
Schweizer,  1992).  Another marker  for the ERGIC is the 
small  GTP-binding  protein rab2p (Chavrier  et al.,  1990). 
Beta-COP, a major component of non-clathrin-coated vesi- 
cles, also associates with the ERGIC at 15°C (Duden et al., 
1991). The p58-positive pre-Golgi elements  described by 
Saraste and Svenson (1991) may also be part of the ERGIC. 
The only membrane protein characterized  and cloned so 
far with a stable ER-Golgi intermediate  localization  is p63 
(Schweizer  et al.,  1993a,b). mAbs against p63 recognized 
an  extended  ER-Golgi  intermediate  membrane  structure 
which indicated  that the ERGIC may be larger  than previ- 
ously suggested by the ERGIC-53 analysis.  Unlike ERGIG- 
53, the distribution  of p63 was insensitive to organelle per- 
turbants such as low temperature and brefeldin A (Schweizer 
et al., 1993a).  Sequence analysis together with biochemical 
data demonstrated that p63 is a nonglycosylated,  reversibly 
palmitoylated type II transmembrane  protein  with  a  106 
amino acid NHe-terminal cytosolic tall,  a single transmem- 
brane domain, and a large extracytoplasmic  domain of 474 
amino acids (Schweizer  et al.,  1993a,b). 
As a first step toward elucidating the mechanisms  that de- 
termine  protein localization  between the rough ER and the 
Golgi  apparatus,  we have studied the retention  of the p63 
marker protein.  In the present paper we demonstrate that all 
three domains of p63 contribute to the proper intracellular 
localization  of this  protein.  Further,  the retention  of p63 
correlated  with  the  formation  of Triton  X-100-insoluble 
1. Abbreviations used in this paper:  ERGIC, ER-Golgi intermediate com- 
partment; DPPIV,  dipeptidylpeptidase  IV; wt, wild type. 
oligomers,  suggesting  that  self-association  of p63 protein 
may serve as a major mechanism for retention. 
Materials and Methods 
Materials 
Enzymes used in molecular cloning were obtained from Boehringer Mann- 
heim (Indianapolis,  IN), New England Biolabs (Beverly, MA), or Promega 
(Madison, WI). DME (4.5 g/1 glucose) and RPMI-1640 medium were from 
GIBCO BRL (Grand Island, NY); FCS from Hazleton Biologics (Lenexa, 
KS);  Nusera  from  Collaborative Biomedical  Products  (Bedford,  MA); 
DEAE-dextran, chloroqulne,  CNBr-activated  Sepharose 4B, and protease 
inhibitors were from Sigma Chemical Co. (St. Louis, MO); ECL western 
blotting reagents from Amersham Corp.  (Arlington Heights, IL); nitrocel- 
lulose from Schleicher and Schuell  (Keene,  NH);  protein A-Sepharose 
beads  from Repligen  Corporation (Cambridge,  MA);  FITC  goat anti- 
mouse IgG from Cappel OVestchester, PA); cell culture dishes from Falcon 
(Becton Dickinson Co., Lincoln Park, NJ); multichamber slides from Nunc 
Inc.  (Naperville,  IL); and human plasma fibronectin from the New York 
Blood Center. 
Oligonucleotides  were synthesized with a solid phase synthesizer (380A; 
Applied Biosystems, Foster City, CA) by the Protein Chemistry Facility of 
Washington University. 
Recombinant DNA 
All basic DNA procedures were as described (Sambrook et al.,  1989). 
P63 Cytoplasmic Tail Mutants. The p63wt cDNA was as described pre- 
viously (Schweizer  et al.,  1993b) and consisted of the 5' untranslated re- 
gion, bpl-84, the 1803 nucleotide coding region and 1023 bp of the 3' non- 
coding sequence.  The full-length cDNA was inserted into the EcoRI site 
in the polylinker of the Bluescript SK- or KS- vector (Stratagene,  La Jolla, 
CA), respectively, with the initiator ATG facing the BamHI restriction site 
of the polylinker.  The resulting constructs were designated pBSK-p63  or 
pBKS-p63, respectively. For transient expression in COS cells, the p63 in- 
sert was subcloned into the EcoRI site of the pECE vector (kindly provided 
by Dr. M. Spiess,  Biozentrum, Basel, Switzerland)  (Ellis ct al.,  1986) to 
give plasmid pECE-p63. 
The mutant forms of the p63 gene were created using standard PCR pro- 
tocols (Ho et al., 1989). All mutants start at bp78 of the original wild type 
(wt) p63 eDNA (Schweizer  et al.,  1993b).  The final PCR products were 
digested with BamHI and used to replace the BamHI-BamHI fragment of 
pBSK-p63. The entire PCR-derived fragment was sequenced by the dideoxy 
termination procedure (Sanger et al., 1977) as described (Schweizer et al., 
1993b). Correct clones were subcloned into the EcoRI site of the pECE vec- 
tor for transient expression in COS cells. 
To generate the A2-101 construct (p63  with deletion of amino acids 
2-101), pBSK-p63 as template together with the 5' primer C-CC CGC CAT 
GCG CAG GCT CGG CAG GC~ G-CT CAA C, and a 3' primer correspond- 
ing to nucleotides  774-791  of the p63wt sequence were used in the PCR 
reaction. In a subsequent PCR reaction, the final A2-101 construct and the 
5' primer AAG GAT CCG AAT TCG CCC GCC ATG GCT GCA CTC 
AGG GCG CTC AAC TIT were used to produce the A2-101 AA 
mutant. 
The same strategy as described for the construction of A2-101 was car- 
tied out for the A16-101 mutant (p63 with a deletion of amino acids 16 to 
101), except for the 5' primer that was GCC CGC CAT GCC CTC GC~ 
CAA ACA AAG ~  CTC CAA GC.K3 CC~ CCA CGG CC_~ CCG CAG 
GCT CGG CAG ~  GCT CAA. 
All other mutations were introduced by the overlap extension technique 
(Ho et al.,  1989) using bp 774-791  of the p63 sequence and bp 170-193 
of  the  Bluescript  KS-  vector  as  downstream  and  upstream  flanking 
primers. An appropriate partial complementary pair of oligonucleotides  in 
which the desired mutation had been incorporated was chosen as internal 
primers. The final PCR products were digested  with BamHI and used to 
replace the BamHI-BamHI fragment ofpBKS-AI6-101 (AI6-101 introduced 
in EcoRI site of pBKS).  Sequencing  and further subcloning were as de- 
scribed above. Alternatively,  final PCR products were directly subcloned 
into the Sinai site of the pECE vector and sequenced. 
For the construction of the A24-101 mutant (p63 with a deletion of amino 
acids 24 to 101), pBKS-p63 A16-101 was used as PCR template.  The inter- 
nal primers were GCC GCG AGC CCC TCG GAG AAG GGT GCC CGC 
AGG CTC GC~ AGG GCG CTC AAC TTT for the downstream reaction 
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GCC GCC CTT GGA GCC CCT for  the  upstream  reaction,  respectively. 
The final  plasmid  was designated  pECE-A24-101. 
Alanine  replacements  of  seven  consecutive  amino  acids  in  the  p63  cyto- 
plasmic  tail were encoded by GCT GCA GCC GCA GCT GCA GCC and 
its complementary sequence.  For the substitution of positively charged 
amino acids and/or glycines within amino acids 1-23 of the p63 sequence 
by alanines, the following codons were used: GCA (for amino acids 5, 7, 
and 21) and GCT (for amino acids 8,  10,  11, and 22). 
P63-DPPIVChimeras. To construct fusion genes of p63 and dipeptidyl- 
peptidase IV (DPPIV), a cDNA for human DPPIV (Misumi et ai.,  1992; 
kindly provided by Dr. Y. Ikehara [Fukuoka  University,  Fukuoka,  Japan]) 
was used. 
For the generation of the PPD and A24-101PPD chimeras (complete or 
A24-101 cytoplasmic tail of 1)63, transmembrane domain of p63,  and lu- 
menal  domain  of DPPIV),  the  DPPIV  cDNA  was  subcloned  into  a 
Bluescript SK- vector that has the KpnI site in its polylinker deleted. A KpnI 
site was then introduced between nucleotides 166 and 171 of the DPPIV se- 
quence without altering the amino acid sequence. The resulting plasmid was 
digested with SalI and KpnI to give a fragment including the complete lu- 
menal domain of DPPIV except for the first 11 nucleotides (bp 160-170). 
The pECE-p63 or pECE-A94-101 plasmid, respectively, were digested with 
SalI and NotI, and the corresponding fragments that encode the complete 
or mutant (A24-101) I)63 cytoplasmic tail plus the first  12 amino acids of 
the p63 transmembrane domain, were isolated.  Two complementary oligo- 
nucleotides corresponding to nucleotides 441-465 of the p63 sequence fol- 
lowed by nucleotides 160-165 of the DPPIV sequence and a KpnI site were 
sequenced and annealed. These components were assembled in a three-part 
ligation to give plasmids pECE-PPD or pECE-A24-101 PPD, respectively. 
All further chimeras were generated by PCR using the overlap extension 
technique (Horton et al.,  1989).  All chimeric constructs were precisely 
joined at the transitions between two domains. Final PCR products were 
treated as described above for the p63 cytoplasmic tail mutants, resulting 
in constructs pECE-DDP (cytoplasmic tail of DPPIV, transmembrane do- 
main of DPPIV, and lumenal domain of p63), pECE-DPP (cytoplasmic tail 
of DPPIV, transmembrane  domain of p63, and lumenal domain of p63), and 
pECE A24-101PDP (A24-101 cytoplasmic tail of p63, transmembrane do- 
main of DPPIV,  and lumenal domain of p63), respectively.  The following 
templates were used for the PCR reactions: plasmids pBSK-p63 and pBSK- 
DPPIV (DPPIV cDNA subcloned as EcoRI fragment into the Bluescript 
KS- vector) to generate constructs DPP and DDP, and plasmids pBKS I)63 
A2.4-101 and pECE-DDP to construct the A94-101PDP chimera. Upstream 
and downstream flanking primers were the same as above. Appropriate pairs 
of partially complementary oligonucleotides  which encoded the desired fu- 
sion were chosen as internal primers. 
All mutants were verified by sequencing at the level of the final plasmid. 
Cell Culture and Transfection 
COS cells (African green monkey kidney cells, CRL 1650; American Type 
Culture Collection, Rockville,  MD) were cultured in DME supplemented 
with 10% FCS,  50 units/ml penicillin, 50 t~g/ml streptomycin,  and fungi- 
zone at 37°C  in a humidified 5% CO: atmosphere. 
For transient tr~ons  COS cells were plated at 17,500-35,000  cells 
per well in an eight-well multichamber slide in which the wells had been 
coated for at least 20 rain with 25 tLg/ml fibronectin in PBS, or at 106 cells 
per 60-mm plate. Suboonfluent cells were washed once with TBS and each 
60-ram plate was exposed to 3/~g of DNA in 1.5 ml RPMI-1640  medium 
containing 10% Nnsera, 50 t~g/ml gentumycin,  100 t~M ehloroquiue,  and 
150/~g/ml DEAE-dextran (RNC plus DEAE-dextran) for 3.5 h. For eight- 
well multichamber slides 0.2/~g DNA in 100/~1 RNC plus DEAE-dextran 
was used in each well. The DNA solution was then replaced with PBS con- 
taining 10% DMSO,  cells were incubated for 2 rain at room temperature, 
and washed with PBS before fresh medium was added. Cells were main- 
tained at 37"C and analyzed 43-48 h after transfection. 
Antibodies 
Mouse mAb G1/296 against the p63 protein has previously been character- 
ized (Schweizer et ai., 1993a). For the detection of DPPIV rnAb HBB 3/775 
(Hauri et al.,  1985) was used. 
Immunofluorescence Microscopy 
cos  cells were grown in eight-well  multichamber slides.  The immuno- 
fluorescence  procedure for permeabilized cells was that of Schweizer et al. 
(1988).  In brief, formaldehyde-fixed and  sapenin-permeabilized cells  were 
incubated with mAb G1/296 against p63 or rnAb HBB 3/775 against DPPIV 
followed by goat anti-mouse FITC. To probe for surface expression of pro- 
teins, COS cells were cooled to 4°C for 20 rain and kept on ice for the subse- 
quent steps.  The cells were washed once with PBS-0.2%  BSA, and in- 
cubated with mAb G1/296 or mAb HBB 3/775 for 45 rain. After six wash 
steps with PBS-0.2% BSA, the cells were fixed with 3% p-formaldehyde 
for 30 rain on ice,  followed by another 30 rain at room temperature. Cell 
permeabilization and staining with goat anti-mouse FITC was as described 
(Schweizer  et ai.,  1988).  The specimens were examined with a  Nikon 
fluorescence  microscope and photographed with 1600 Fujichrome film. 
Immunoblotting 
After two washes with PBS, transfectod COS cells of one 60-ram plate were 
scraped into 1 ml PBS and centrifuged for 10 rain at 800 rpm (132 giv). 
The pellet was resuspended in 800/~1 MNT buffer (20 m_M MES,  30 mM 
Tris,  100 mM NaCl,  1.25 m_M EDTA, and 1 mM EGTA) at various pHs 
containing 1% Triton X-100, 100 mM iodoacetamide, 40 t~g/mi PMSF, and 
a 1:500 dilution of a protease inhibitor cocktail (5 mg/mi benzamidine and 
1 mg/ml each of pepstatin A, leupeptin, antipain, and chymostatin in 40% 
dimedaylsnifoxide, 60 % ethanol) by passing it five times through a 25-gange 
needle connected to a 1-ml syringe.  After a  1-h solubilization step on ice, 
the cells were centrifuged for 60 rain at 39,000 rpm (100,000 g~v) in a Ti 
50 rotor (Beckman Instnmaents Inc., Paio Alto, CA). The resulting super- 
natants were  carefully  harvested and proteins were precipitated by the 
method of Wessel and Fluegge (1984). The precipitates were solub'~,ed in 
Laemmli buffer (Laemmli, 1970). The pellets in the Ti 50 tubes following 
centrifugation  were selubilized directly in sample buffer and sonicated. Pro- 
teins  were  separated  on  8%  SDS-polyaerylamide  minigels  (Bio  Rad 
Laboratories, Richmond, CA) using the Laemmli (1970) system, and trans- 
ferred to nitrocellulose membranes according to the method of Towbin et 
al. (1979).  For the immunoreaction, the nitrocellulose sheet was blocked 
with 3 % nonfat dry milk powder  in PBS,  incubated with mAb G1/296 
against p63  (diluted  1:5,000 in PBS-3%  powdered  milk) followed by a 
horseradish peroxidase-conjugated  anti-mouse secondary antibody (Amer- 
sham Corp.).  For development the  ECL  detection system  (Amersham 
Corp.) was used according to the manufacturer's directions. 
Quantification of autoradiograms was carried out by means of a Molecu- 
lar Dynamics Personal Densitometer (Sunnyvale,  CA). 
Affinity Purification of  p63 Protein 
cos  cells (10-12 60-mm plates per preparation) transfected with either 
p63wt or A2-101AA were washed twice with PBS, scraped into 1 ml PBS 
per plate and centrifuged for 10 min at 800 rpm (132 ga~). Each pellet was 
resuspended in 500/~1 of buffer 2 (100 mM Na2HPO4, pH 8.0, 1% Triton 
X-100), containing 100 mM iodoacetamide,  40/~g/ml PMSF, and a 1:500 
dilution of the above described protein inhibitor cocktail by passing it five 
times through a 25-gang¢ needle connected to a  1-ml syringe.  After a  1-h 
solub'dization step on ice, the cells were centrifuged for 60 rain at 39,000 
rpm (100,000 gay) in a Ti 50 rotor. P63 proteins were affinity purified from 
the resulting supernatants on a column of mAb G1/296 coupled to cyanogen 
bromide-activated Sepharose 4B. mAb G1/296 had been purified from cul- 
ture supernatant by ammonium sulfate precipitation (to 50 % saturation) fol- 
lowed by protein  A-Sepharose chromatography prior to coupling  according 
to the suppliers instructions. P63 proteins were eluted with 0.1 M glycine, 
pH 3.0, 0.05 % Triton X-100, and immediately adjusted to pH 8.0 with 1 M 
"Iris base.  After analysis by SDS-PAGE,  fractions that revealed  a single 
band of appropriate size (Schweizer, A., J. Rohrer, and S. Kornfeld, unpub- 
lished data) were pooled and dialyzed against MNT buffer, pH 8.0, contain- 
ing 0.05% Triton X-100. Protein was determined with the micro BCA pro- 
tein assay (Pierce,  Rockford,  IL). 
pH Shift Experiment 
MNT buffer, pH 8.0, containing 1% Triton X-100 was added to 0.75/~g of 
purified p63wt or A2-101AA protein to a final volume of 700 td before one 
of three incubations was carried out. The first sample was incubated for 40 
rain on ice.  The second sample was brought to pH 5.8 by addition of a 
pretitrated volume of 1 N HC1 and then incubated on ice for 40 min. The 
third sample was shifted to pH 5.8 and incubated on ice for 40 rain; the pH 
was then returned to 8.0 by addition of a pretitrated volume of 1 N NaOH 
followed by another 40 roan on ice. All samples were centrifuged for 60 min 
at 39,000 rpm (I00,000 gay) in a Ti 50 rotor. The resulting supernatant and 
pellet fractions were further treated as described under immunoblotting. 
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Expression of  p63 cDNA in COS Cells 
The endogenous p63 could be visualized in saponin-perme- 
abilized COS cells by indirect immunofluorescence using a 
1:20 dilution of mAb G1/296 which is specific for this pro- 
tein. As shown in Fig. 1 a, the fluorescence pattern with its 
extended ER-Golgi intermediate membrane structure was 
very  similar to  that observed  previously with Vero  cells 
(Schweizer et al., 1993a). While ER-like, the pattern differs 
from that observed with ER markers in that it is less reticular 
and the outer nuclear membrane does not stain (see Fig. 2 
c  for a  typical ER pattern and Schweizer et al.,  1993a). 
When the mAb G1/296 was tested at a dilution of 1:2,000, 
the p63 staining pattern was very faint (Fig. 1 b). Since this 
dilution of antibody gave a strong signal with p63 transfected 
COS cells (Fig. 2 a), it was possible to readily distinguish 
between endogenous and transfected p63.  COS cells trans- 
fectext with IRi3wt exhibited the typical extended membrane 
structure observed when endogenous p63 was stained (Fig. 
2 a, left cell). In addition, some of the cells showed a large 
tubular network pattern that was not observed in the untrans- 
fected COS cells (Fig.  2 a,  right cell)  (Schweizer et al., 
1993b).  P63wt was never detected at the cell surface, even 
when the expression level was very high (Fig. 2 b). 
The Cytoplasmic  Domain of  p63 Is Necessary 
for Retention 
In our attempt to determine the features of p63 responsible 
for retention we initially concentrated on the cytoplasmic do- 
main of the protein. The first construct to be prepared was 
a  truncated  form  of  p63  in  which  the  amino-terminal 
residues  2-101  of the  106-amino  acid-long p63  tail were 
deleted (A2-101, Fig. 3). Since p63 has a type II membrane 
orientation, the first NH2-terminal amino acid representing 
the initiator methionine could not be removed. When A2-101 
was expressed in COS cells, it was clearly present on the 
plasma membrane in about half of the transfected cells (Fig. 
2 d). Upon permeabilization, A2-101 was detected primarily 
in the rough ER as indicated by the reticular staining pattern 
along with labeling of the outer nuclear membrane (Fig. 2 
c).  Occasionally it was found in the Golgi region or at the 
cell surface (see insert of Fig. 2 c for an example of surface 
staining).  In  the  construction  of  A2-101, two  arginine 
residues became positioned near the extreme NI-I2-terminus 
due to the deletion of 100 amino acids within the cytoplas- 
mic tail (Fig. 3). We therefore considered the possibility that 
these positively charged amino acids might serve as an ER- 
targeting signal, thereby impairing the normal transport of 
the protein (Jackson et al.,  1990).  These arginine residues 
(located in position -2  and -3  from the NH2  terminus of 
A2-101) were therefore changed to alanines (A2-101AA, Fig. 
3) and the effect monitored by immunofluorescence as out- 
lined above.  A2-101AA showed strong cell surface expres- 
sion over the entire transfected cell population (Fig. 2 f). 
Further, the staining pattern observed in permeabilized cells 
(Fig. 2 e) was typical for a cell surface protein including  jux- 
tanuclear Golgi and plasma membrane staining. Taken to- 
gether, these data demonstrated that the cytoplasmic domain 
of p63  is necessary for correct intracellular localization. 
The l~rst 23 Amino Acid Residues of  p63 Contain an 
Important Signal 
To define more precisely the location of the retention infor- 
mation in the p63 cytoplasmic tail we made a construct (A16- 
101, Fig. 3) in which amino acids 2-15 of p63wt were added 
back to the A2-101 deletion mutant. When cells expressing 
this construct were analyzed by immunofluorescence, an in- 
ternal staining pattern close to that of p63wt was observed 
except that no cells with the tubular network type pattern 
were found (Fig. 4 a). Labeling of nonpermeabilized COS 
cells with anti-p63 mAbs revealed that A16-101 is predomi- 
Figure 1. Immunofluorescence  localization  of  endogenous  p63 in COS cells. COS ceils were fixed  with paraformaldehyde  and permeabilized 
with saponin. The cells were labeled with mAb G1/296 against p63 at a dilution of 1:20 (a) or 1:2,000 (b), respectively,  followed  by FITC- 
labeled goat anti-mouse antibody. Note that the antibody dilution used in (b) allowed clear distinction of endogenous from transfected 
p63 in subsequent immunofluorescence  experiments. Bar, (a) 17 #m; (b) 42 #m. 
The Journal  of Cell Biology,  Volume 126, 1994  28 Figure 2. The cytoplasmic  tail of  p63 is necessary for retention. P63wt (a and b), A2-101 (c and d), and A2-101AA (e and  f) were expressed 
by transient transfeetion of COS cells and localized by indirect immunofluorescenee  of saponin-permeabilized  (a, c, and e) and nonperme- 
abilized (b, d, and f) cells. For detection an mAb to p63 followed  by goat anti-mouse FITC was used. In contrast to p63wt, constructs 
A2-101 and A2-101AA were observed at the plasma membrane. Bar, (a and b) 28/~m; (c-f) 42/~m. 
nantly localized intracellularly (Fig. 4 b); an occasional cell 
showed weak staining of the plasma membrane (Fig. 4 b, in- 
set). When the NH~-terminal portion of p63 was extended 
to include the 23  NH2-terminal residues of the p63wt se- 
quence (A24-101, Fig. 3), the resultant protein behaved like 
p63wt when analyzed by indirect immunofluorescence after 
transfection (Fig. 4, c and d). The mutant protein was com- 
pletely retained inside the cell (Fig. 4 d). In addition, the 
A24-101 staining in permeabilized ceils was indistinguish- 
able from that ofp63wt (Fig. 4 c), including cells that exhibit 
the striking tubular network that is typically found in p63wt- 
transfected ceils (Fig. 4  c,  inset).  We conclude from these 
results that the NH~-terminal 23 amino acid residues of the 
p63 cytoplasmic domain are required for proper intracellular 
localization. Deletion of amino acids 24-101 of the p63 tail, 
on the other hand, had no detectable effect  on the distribution 
of p63 in the cell. 
To further define the sorting determinant that is present 
within amino acids 1-23 of p63, this region was subjected to 
extensive site-directed mutagenesis. First, a series of over- 
lapping alanine stretches was created in the A24-101 mutant. 
As indicated in Fig. 5 A, amino acids 2-8 (A24-101, 2-8A), 
amino acids 6-12 (A24-101,6-12A), amino acids 9-15 (A24- 
101,9-15A), amino acids 13-19 (A24-101, 13-19A), or amino 
acids  17-23  (A24-101,  17-23A), respectively, were  simul- 
taneously changed to alanines using PCR mutagenesis. Sur- 
prisingly, these substitutions had no detectable effect on the 
localization of p63. Immunofluorescence of transfected non- 
permeabilized cells showed that none of the mutants were 
transported to the plasma membrane (for an example see 










lqgure  3.  Schematic iUustra- 
tion of deletion mutants within 
the  cytoplasmic  tail  of p63. 
Selected amino  acids of the 
p63  cytoplasmic  tail  are 
shown  (single letter  code). 
Boxes  represent  the  single 
ummnembrane domain of p63. 
Lines indicate deleted regions 
of the p63 sequence. The mu- 
tants are named by the posi- 
tion  of  their  deletions  as 
shown at the left margin of the 
figure. 
Fig. 6 b). The internal distribution of  the constructs was also 
indistinguishable from that of/,24-101 or p63wt (for an ex- 
ample see Fig. 6 a). 
When a similar type of alanine scan was carried out in the 
m6-101 background (Fig.  5 B), a  different result was ob- 
tained. All of the mutant proteins exhibited some degree of 
increased transport to the cell surface, with the zk16-101,6- 
12A mutant showing the strongest effect (Fig. 6 d).  When 
COS cells transfected with this mutant were permeabilized, 
the predominant staining pattern was characteristic for the 
ER and the Golgi apparatus  indicating that/,16-101,6-12A 
had lost p63wt localization (Fig.  6  c). 
These results clearly show that alanine substitutions have 
an effect when only amino acids  1-15  (/,16-101)  instead of 
amino acids 1-23 (/,24-101)  of the p63 cytoplasmic tail are 
present. One possible explanation for this finding could be 
the existence of a redundant signal with one of the compo- 
nents being located within residues 16-23. 
When we carefully inspected the critical p63  sequence, 
a repetitive feature consisting of a positively charged amino 
acid followed by a glycine residue became apparent. The se- 
quence contains an arginine-glycine combination at amino 
acid positions 7 and 8, and two pairs of lysine-glycine at po- 
sitions 10 and 11, and 21 and 22, respectively. In addition, 
Figure 4. Immunofluorescence microscopy of  transiently transfected COS cells expressing A16-101 (a and b) and A24-101 (c and d). Fixed, 
permeabilized (a and c) or nonpermeabilized (b and d) cells were stained with a mouse mAb to p63 and fluoreseein-conjugated antibodies 
to mouse IgG. Note that A24-101 behaved indistinguishable from p63wt. Bar, 28 #m. 
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MP  SAKQRG  SKGGHGAASP SEKGARRLGR I 
l  I 
i  I 
i  I 
)  I 
A24-I01,17-23A  I  I 
Figure 5.  Alanine scan of the 
B  cytoplasmic tail of (,4) A24- 
s  10  is  101  and  (B)  AI6-101.  The 
A16-101  MP SAKQRGSKGGHGARRLGPJ  amino acids  of  the cytoplas- 
mic  tail of A24-101 and A16- 
A16-101,2-8A  }  [  101  are  shown  (single letter 
code).  Boxes  represent  the 
single transmembrane domain 
A16-101,6-12A  I  [  of p63.  Bars  indicate amino 
acids of the wt sequence sub- 
A  16-10  I,  9-15A  l  [  stituted  by alanines. 
Figure 6. Immunofluorescence localization of selected constructs from the alanine scans shown in Fig. 5. COS cells were transfected with 
A24-101,6-12A (a and b) and A16-101,6-12A (c and d) and labeled with mAb G1/296 against p63 followed by goat anti-mouse FITC with 
(a and c) or without (b and d) permeabilization. Bar, 42 #m. 
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A2 4-101  MP SAKQRGSKGGHG~SP  SEKGARRLGRI 
MPI  (A24-101,K  ~R~ 
G-~K:ZG::Ke:G22-A 
A-AA-AA  AA  I 
[  Figure  7.  Point mutations 
within the cytoplasmic tail of 
~.4-101. The amino acids of 
the cytoplasmic tail of ~O.4- 
101 are given in single letter 
[  code. Boxes represent the sin- 
gle  p63  transmernbrane do- 
main. Amino acids in the cy- 
toplasmic  tail  replaced by 
I  alanines are shown. 
MP2  (A24-I01,  K~R7  ....  A-A--A  A 
K::K;:-A) 
MP3  (A24-I01,  GSG::  .......  A--A  A' 
G~>-A) 
MP  4 (A24-I01, RTG  8  AA-AA  AA 
K::G: :K2:G~-A) 
there is a single lysine residue present at amino acid position 
5.  The distribution of these residues relative to the amino 
acids altered in the overlapping alanine substitution experi- 
ments was consistent with these residues serving as com- 
ponents of a redundant retention signal. To test this possi- 
bility, K  ~,  R  7,  G  s,  K 1°,  G H,  K  21,  and G 22 in the ~24-101 
sequence were simultaneously changed to aianines (Z~.4- 
101,KSRTGSKI°GnK2tGa2-A [MP1]; Fig. 7). Immunofluores- 
cence analysis of  this mutant expressed in COS cells revealed 
that it was highly expressed at the plasma membrane of non- 
permeab~  transfected cells (Fig. 8 b). Furthermore, in 
permeabilized ceils transfected with MP1 the staining was 
also  characteristic  for a  surface protein  (Fig.  8  a).  The 
phenotype of MP1 is therefore very similar to that of  the tail- 
minus mutant A2-101AA. 
We next tested whether alunine substitutions of only the 
positively charged amino acids (K  s, W, K 1°, and K29 (A24- 
101,KSRTK'°Ke~-A [MF2]; Fig. 7) or only the glycine resi- 
dues (C_J, G n, and Cr  n) (A94-101,CJG"G22-A [MP3]; Fig. 7) 
present in the K-RG-KG-KG element would also disrupt p63 
localization. Both constructs behaved similarly to A24-101 
and p63wt as indicated by the lack of cell surface staining 
(Fig. 8, d and f) and the typical internal pattern (Fig. 8, c 
and e). This demonstrated that changing positive charges or 
glycines alone does not affect retention of p63. 
An additional construct was created that has the same mu- 
tation as MP1  except for amino acid position 5 where the 
original lysine was retained (A94-101, RTG-SKt0GttK2tC_F'-A 
[MP4];  Fig.  7).  Following transient transfection and im- 
munofluorescence microscopy, this mutant showed two dif- 
ferent localizations. Some of the chimeric protein was con- 
sistenfly detected on the cell surface (Fig. 8 h) while the re- 
rnaining protein was predominantly found in the ER (Fig. 8 
g). The latter finding suggested that the introduced changes 
might partly impair proper  folding of the mutant protein 
which may prevent its exit from the ER.  The presence of 
MP4 at the cell surface shows that K  5 cannot restore correct 
localization of p63  in the absence of the three positively 
charged amino acid-glycine combinations. 
Analysis of Chimeric Proteins between p63 and a 
Plasma Membrane Protein 
To further analyze the role of the cytoplasmic tail of p63 in 
retention and to determine whether the transmembrane and 
lumenal domains of this protein contribute to proper intra- 
cellular localization, we substituted each of these domains 
with the corresponding domains of the cell surface protein 
human DPPIV (Fig. 9). The serine protease DPPIV is a type 
II integral membrane protein like p63 and is found on a vari- 
ety  of epithelial,  endothelial and lymphocytic cell types 
(Hong and Doyle, 1987, 1990;  Ogata et al.,  1989). 
We first analyzed a chimeric protein (DPP;  DPPIV cy- 
toplasmic,  p63  transmembrane,  p63  lumenal;  Fig.  9)  in 
which the cytoplasmic tall of DPPIV was fused to the trans- 
membrane and lumenal domains of p63.  COS cells were 
transfected with DPPIVwt or the chimeric construct and the 
localization of the proteins was examined by indirect immu- 
nofluorescence of  permeabilized and nonpermeabilized cells 
using mAbs to a lumenal epitope of each protein. Nontrans- 
fected control cells did not react with the anti-DPPIV mAb 
(data not shown) consistent with evidence that COS cells 
have tittle or no endogenous activity of DPPIV (Ogata et ai., 
1992).  As shown in Fig. 10, a and b DPPIVwt was located 
on the cell surface as expected. Bright cell surface staining 
was also observed for DPP (Fig.  10 d).  However,  unlike 
DPPIVwt a portion of DPP was also found in the ER (Fig. 
10 c), indicating that the export of this chimeric protein out 
of the ER is impaired to some extent: Very  rarely a  cell 
showed a  p63wt-related staining pattern.  A  similar result 
was obtained with a  construct that only contained the lu- 
menal domain of p63  (DDP;  DPPIV cytoplasmic; DPPIV 
transmembrane, p63 lumenal; Fig. 9) except that most of  the 
ER staining was now replaced by cell surface expression 
(data not shown). These results confirm that the p63 cyto- 
plasmic tail is necessary for proper localization. In the ab- 
sence of the p63 cytoplasmic tail, the lumenal p63 domain 
alone or in combination with its transmembrane domain is 
not sufficient to achieve retention. 
We next asked whether the lumenal domain of p63 is dis- 
pensable for the correct targeting of the protein. To this end, 
a chimeric construct in which the lumenal domain of  p63 was 
replaced by that of DPPIV  (PPD,  p63  cytoplasmic, p63 
transmembrane, DPPIV lumenal; Fig. 9) was created. In a 
related construct we linked the cytoplasmic and transmem- 
brane domains of A24-101 to the DPPIV lumenal domain 
(A24-101PPD, p63 with deletion of amino acids 24-101 cyto- 
The Journal of Cell Biology, Volume 126,  1994  32 Figure 8. Identification of cytoplasmic residues critical for correct localization of p63. Constructs MPI (a and b), MP2 (c and d), MP3 
(e and f), and MP4 (g and h) were expressed in COS ceils and localized by indirect immunofluorescence of permeabilized (a, c, e, and 
g) and nonperrneabilized (b, d, f  and h) cells. For detection an anti-p63 mAb and goat anti-mouse FFI'C were used. MP1 and MP4, but 
not MP2 and MP3 were found at the cell surface. Bar, 42/zm. 
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of the  p63wt  and  DPPIVwt 
proteins,  and of p63-DPPIV 
chimeras. P63 sequence is in- 
dicated as striated bars, while 
sequence derived from DPPIV 
is shown as dotted bars. Num- 
bers indicate amino acid posi- 
tions at the beginning or end 
of topological domains. Chi- 
meras are basically named by 
a three letter code indicating 
the  origin  of their  cytoplas- 
mic, transmembrane, and lu- 
menal domains (left margin of 
figure) 
plasmic,  p63  transmembrane,  DPPIV  lumenal;  Fig.  9). 
When the subeellular localization of the chimeric proteins 
was analyzed in transfected COS cells, A24-101PPD  showed 
the same distribution as DPPIVwt. There was strong labeling 
of the cell surface (Fig.  10 f), but no internal staining with 
a p63wt pattern (Fig. 10 e). The same was true for the PPD 
chimera (Fig.  10, g  and h) except that the internal staining 
pattern included more ER staining in addition to the Golgi 
and cell surface staining predominantly found for DPPIVwt 
and A24-101PPD.  These data demonstrate that the presence 
of the lumenal domain of the p63 molecule is essential for 
the correct localization of the protein. 
The results with the PPD and A24-101PPD  constructs to- 
gether with the mutational analysis of the p63 cytoplasmic 
tail establish that the transmembrane domain of p63 is not 
sufficient for its localization. To determine whether this do- 
main is a  necessary component, we created an additional 
chimera that combines a p63 cytoplasmic tall that has amino 
acids  24-101  deleted with the transmembrane  domain  of 
DPPIV and the lumenal part of p63 (A24-101PDP;  p63 with 
deletion of amino acids 24-101 cytoplasmic, DPPIV trans- 
membrane, p63 lumenal; Fig. 9). Immunofluorescence mi- 
croscopy of transfected cells showed that the internal distri- 
bution of A24-101PDP is very similar to p63wt (Fig.  10 i). 
Unlike p63wt, however, some A24-101PDP  molecules were 
detected on the plasma membrane in unpermeabilized cells 
(Fig.  10 j).  The intensity of this cell surface staining was 
fainter than that of DPPIVwt or any of the other chimeric 
constructs. Thus, while the transmembrane domain contrib- 
utes to the complete intracellular retention of p63, it appears 
to be less important for the overall localization than its cyto- 
plasmic and lumenal counterparts. 
Oligomerization  of  p63 Correlates with Its Retention 
The retention behavior of  p63 described so far suggested that 
the underlying molecular mechanism might be related to 
physical properties within the p63 protein itself. Two find- 
ings  in  particular  supported  this  idea.  First,  overexpres- 
sion of p63 did not saturate the retention mechanism. And 
second, the p63 localization could not be transferred to an- 
other protein. We therefore speculated that individual 1363 
molecules might interact with each other to form higher or- 
der structures. To test this hypothesis p63wt was analyzed by 
centrifugation. In this experiment COS cells transfected with 
p63wt were solubilized with Triton X-100 at different pHs 
(5.8, 6.3, 6.8, 7.4, and 8.0) and then subjected to centrifuga- 
tion at 100,000 g for 1 h. The resulting supernatant and pellet 
fractions were then assayed for the presence of p63 by SDS- 
PAGE and immunoblotting with an anti-p63 mAb. As shown 
in Fig.  11 A there was a pH dependent shift of 1363 from the 
soluble fraction to the pellet. At pH 8.0, p63 was equally dis- 
tributed  between  the  pellet  and  supernatant  fractions, 
whereas increasing amounts of p63 were recovered in the 
Figure 10. Immunofluorescence localization of DPPIV and p63-DPPIV chimeras. Transfected COS ceils expressing DPPIVwt (a and b), 
DPP (c and d), A24-101PPD (e and f), PPD (g and h), or A24-101PDP (i and j) were stained with mAb HBB 3/775 against DPPIV (a, 
b, e,f, g, and h) or mAb G1/296 against p63 (c, d, i, and j) followed by goat anti-mouse FITC with (a, c, e, g, and i) or without (b, 
d, f, h, and j) permeabilization. All chimeric constructs were detected at the cell surface. Notice the fainter plasma membrane staining 
of A24-101PDP. Bars: (a-h and j) 42 ~m; (i) 28/~m. 
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COS cells transfected with p63wt  were  solubilized with Triton 
X-100 at the indicated pHs and then separated by centrifugation at 
100,000 g into supernatant (S) and pellet (P). Proteins of the two 
fractions were subjected to SDS-PAGE (8% gels) and immunoblot- 
ring with an anti-p63 mAb. The numbers at the left margin of the 
blot indicate known molecular mass in kilodalton. (B) Samples of 
affinity purified p63wt protein  (lanes 1-6)  or A2-101AA (lanes 
7-10) in MNT pH 8.0-Triton X-100 were incubated for 40 rain (I), 
adjusted to pH 5.8 and then incubated for 40 rain (II), or shifted 
to pH 5.8 for 40 mill, then returned to pH 8.0 and incubated for an- 
other 40 rain (III). Separation into supernatant (S) and pellet (P) 
and further analysis was as described in A. 
pellet as the pH decreased. When the experiment was per- 
formed with nontransfected COS cells at pH 7.4, 94 +  8% 
of the endogenous p63 was recovered in the pellet fraction. 
This demonstrates that p63 oligomerization occurs at physio- 
logic protein concentrations, excluding the possibility that 
this property is a special feature of transfection and/or over- 
expression. Similar results were obtained with affinity-puri- 
fied p63,  as  shown  in  Fig.  11  B  (lanes  1-6).  In  this  ex- 
periment, purified p63 kept at pH 8.0 remained completely 
soluble (lanes 1  and 2).  When the pH was shifted to 5.8, 
about half of the proteins formed oligomers that sedimented 
at 100,000 g centrifugation (lanes 3 and 4). This oligomer- 
ization was completely reversed by restoring the pH to 8.0 
(lanes 5  and 6).  Taken together, these results indicate that 
p63 forms Triton X-100-insoluble oligomers, especially at 
neutral pH and below. 
We next tested whether the ability of p63 to oligomerize 
correlated with retention and proper localization. To address 
this  point,  a  selected set of p63  cytoplasmic tall mutants 
were expressed in COS cells and the transfected ceils were 
then solubilized with Triton X-100 at pH 6.5  and analyzed 
as described above. The results of a typical experiment are 
shown in Fig.  12 A and the quantitation of multiple experi- 
ments is given in Fig. 12 B. P63wt which served as a control 
was exclusively found in the pellet fraction (97 ±  5 %). A24- 
101, MP2,  and MP3 which have intraceilular distributions 
Figure 12. Otigomerization of  p63 correlates with its retention. (,4) 
COS ceils were trmsfeoed with wt or mutant p63, solubRized  with 
Triton X-100 at pH 6.5 and further analyzed as described in Fig. 
11. (P) pellet, (S) supematant. The upper band seen in the pellet 
lanes of  p63 mutants represents endogenous p63 that is exclusively 
found in the pellet fractions. (B) The immtmoblots shown in A and 
those from additional experiments were quantitated by densitomet- 
ric scanning. For each sample (x-axis) the amount of wt or mutant 
1063 detected in the supernatant (dotted light bars) and pellet (stri- 
ated dark bars) fraction, respectively, is plotted as the percentage 
of p63 present in both fractions (y-axis). Each value is the average 
of at least four independent experiments. The standard deviations 
were ,g8.5  %. 
similar to p63wt were also recovered predominantly in the 
100,000 g pellet (81 +  9%, 78 +  4%, and77 ±  5%, respec- 
tively). In contrast, A2-101AA and MP1 which are not local- 
ized properly, were found mainly in the supernatant fraction 
(75 ±  2 %, and 83 ±  2 %, respectively). The upper band de- 
tected in the pellet lane of each of  the p63 mutants represents 
endogenous  p63  from  COS  ceils.  Similar  to  transfected 
p63wt, endogenous 1363 was exclusively found in the pellet 
fraction regardless of  the behavior of the transfected p63 mu- 
tants and therefore served as a useful internal standard for 
the distribution of the various mutants. Affinity-purified A2- 
101AA gave similar results to those obtained with homog- 
enates of COS ceils transfected with A2-101AA (Fig.  11 B, 
lanes  7-10). 
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retention of p63 and the formation of Triton X-100-insoluble 
complexes. 
Discussion 
Previous studies have established that p63 is stably retained 
between the rough ER and the Golgi apparatus  (Schweizer 
et al.,  1993a).  In the present study, we have analyzed the 
contribution of the individual  p63 domains to retention  by 
creating  chimeric constructs with the type II plasma mem- 
brane protein DPPIV.  The role of the cytoplasmic tail was 
further analyzed by deletions and point mutations within the 
p63 protein itself. The appearance of mutant p63 proteins at 
the cell surface and the concomitant loss of the characteristic 
p63wt internal  staining pattern were used as criteria for loss 
of proper retention.  Using these approaches,  we have iden- 
tiffed the domains of p63 that determine retention and ob- 
tained data that are consistent with the notion that oligomer- 
ization  of p63 serves as a major retention mechanism. 
Table I presents a summary of all the constructs analyzed 
in this study. The striking  characteristic  of p63 retention  is 
that no  single topological domain  is  sufficient  to specify 
retention.  Rather, all three domains are required to achieve 
complete intracellular  retention.  The cytoplasmic and lu- 
menal domains of p63 are most important for proper local- 
ization with the transmembrane domain playing a lesser role 
in this process. These findings with p63 differ from those ob- 
tained with most other proteins of the early secretory path- 
way where one domain has been shown to be sufficient for 
retention.  In the case of resident lumenal ER proteins,  the 
four-amino acid sequence KDEL at the carboxyl terminus 
serves as retrieval signal (Munro and Pelham,  1987; Pelham, 
1989, 1990). Similarly, KKXX/KXKXX elements at the car- 
boxyl terminus  of the cytoplasmic domains of type I trans- 
membrane proteins function as retrieval  signals (Nilsson et 
al.,  1989; Jackson et al.,  1990, 1993).  When transplanted 
onto marker proteins,  these sequences are sufficient to cause 
retention in the ER. The carboxyl-terminal cytoplasmic do- 
main of TGN38 is also sufficient for localization of chimeric 
proteins to the TGN (Bos et al.,  1993;  Humphrey et al., 
1993;  Wong  and  Hong,  1993).  Other  Golgi proteins  are 
localized by means of their transmembrane domains (N-ace- 
tylglucosaminyltransferase  I (Burke et al., 1992; Tang et al., 
1992),  galactosyltransferase (Nilsson et al.,  1991; Aoki et 
al.,  1992;  Russo et al.,  1992),  and the M glycoprotein of 
avian coronavirus (Swift and Machamer,  1991; Machamer 
et al.,  1993) or in association with the cytoplasmic and lu- 
menal flanking  sequences (or 2,6-sialyltransferase  (Munro, 
1991; Dahdal and Colley, 1993). The E1 glycoprotein of the 
mouse coronavirus is an exception among the proteins local- 
ized to the Golgi apparatus  (Armstrong and Patel,  1991). 
While  a  short  deletion  in  the  cytoplasmic tail  destroyed 
retention,  the cytoplasmic segmet~t alone was not sufficient 
for retention.  Similar to the finding with p63, most of the se- 
quence appeared to be required for proper localization. 
Molecular dissection of the cytoplasmic tail of p63 iden- 
tiffed the NH2-terminal  23 amino acids as being necessary 
for retention whereas amirio acids 24-100 were dispensable 
for this  function. Within  the NH2-terminal  sequence, sub- 
stitution  of three pairs of amino acids each consisting  of a 
positively charged amino acid followed by a glycine residue 
Table I. Summary of  lmmunofluorescence  Analysis of  p63wt 
and Mutant Proteins 
Construct  tgi3wt pattern  Surface staining 
p63wt  yes  no 
A2-101  no  yes 
A2-101AA  no  yes 
A16-101  yes*  no~ 
A24-101  yes  no 
A24-101,2-8A  yes  no 
A24-101,6-12A  yes  no 
A24-101,9-15A  yes  no 
A24-101,13-19A  yes  no 
A24-101,17-23A  yes*  no 
AI6-101,2-SA  no§  yes 
A16-101,6-12A  no  yes 
A16-101,9-15A  no§  yes 
MP1  no  yes 
MP2  yes  no 
MP3  yes  no 
MP4  no  yes 
DPPIVwt  no  yes 
DPP  noll  yes 
DDP  noll  yes 
A24-101  PPD  no  yes 
PPD  no  yes 
A24-101  PDP  yes  yesl 
* Except no cells with tubular network pattern. 
~: Occasional cells showed weak staining of the plasma membrane. 
§ Some cells showed a p63wt-related staining pattern. 
~  Very rarely a cell showed a p63wt-related staining pattern. 
The intensity of this cell surface staining was fainter than that of DPPIVwt 
or other chimeric constructs. 
(R  7, C  -s, K ~°, G It , K  2~, and G 22) by alanines  (MP4) resulted 
in transport of the mutant protein to the plasma membrane, 
indicating the importance of the corresponding amino acids 
for correct localization of p63. Interestingly,  changing either 
the positively charged residues or the glycines alone (MP2, 
MP3) did not affect retention  of p63. Further,  the dements 
required for retention  appear to be at least partly redundant 
as revealed by the analysis  of the overlapping  alanine  scan 
of A24-101, a similar  scan of AI6-101, and the cytoplasmic 
tail deletion mutants. 
What is the role of the cytoplasmic tail in conferring proper 
intracellular  retention  of p63?  A  potential  clue emerged 
when we analyzed the solubility of the various constructs in 
the nonionic detergent Triton X-100. When transfected  cells 
were solubilized  with Triton X-100 at pH 6.5 and then sub- 
jected to ultracentrifugation  at 100,000 g, the proteins that 
were properly retained (p63wt, A24-101, MP2, and MP3) 
were predominantly found in the pellet fraction whereas the 
nonretained proteins (A2-101AA and MP1) were mostly re- 
covered in the supernatant.  Endogenous p63 from COS cells 
was exclusively found in the 100,000 g pellet, demonstrating 
that the property is not a function of transfection and/or over- 
expression.  While the extent of Triton X-100-insolubility of 
p63wt increased with decreasing pH, most of the protein was 
insoluble at pH 7.4, which is similar to the pH of the cyto- 
plasm. Since highly purified p63wt exhibited the same pH- 
dependent insolubility in Triton X-100, we conclude that this 
behavior is an intrinsic property of the protein.  This does not 
exclude the possibility that p63 also interacts with other resi- 
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ments,  such as members of the cytoskeleton. 
The striking  correlation between proper intracellular  lo- 
calization and Triton X-100-insolubility  suggests a retention 
mechanism for p63 that involves homooligomerization.  The 
model predicts  that  upon arrival  at their final destination, 
p63 molecules encounter an environment  that leads to self 
aggregation  resulting  in the formation  of large  oligomers. 
The specific conditions  that might trigger  the oligomeriza- 
tion of p63 are unknown, but could include differences in ion 
composition, lumenal  pH or properties of the local mem- 
brane.  This  proposed retention  mechanism  is  compatible 
with several additional findings. First, high levels of expres- 
sion do not result in mislocalization  of p63 to the plasma 
membrane,  indicating  that the p63  retention  system is not 
saturable.  If p63 interacted with a specific receptor,  overex- 
pression would likely lead to saturation  of the retention ma- 
chinery and the appearance of the protein at the cell surface. 
Second, as mentioned  above, all three domains of p63 are 
necessary for complete retention,  as would be expected if 
the molecule formed higher  order structures.  When Triton 
X-100-soluble p63 molecules were examined by sucrose gra- 
dient centrifugation  or nonreducing  SDS-PAGE, the major- 
ity of the molecules were present as noncovalently  linked 
dimers (Schweizer et al.,  1993a;  Schweizer, A., J. Rohrer, 
and S. Kornfeld,  unpublished data).  Interestingly,  this  di- 
merization  of p63 is independent  on the cytoplasmic tail, in 
contrast to the formation  of higher  oligomeric complexes. 
Taken together, the most straightforward  interpretation  of 
our results is as follows. The lumenal domains of individual 
p63 molecules interact to form noncovalently linked dimers, 
with the transmembrane domains possibly having an acces- 
sory role. These dimers would represent the basic unit from 
which higher oligomeric structures are built. Upon reaching 
their final destination,  larger complexes form, requiring  in- 
teractions  of the cytoplasmic tails as well as the lumenal and 
transmembrane domains. The amino-terminal  23 residues of 
the cytoplasmic tails could either be directly involved in the 
interactions  or, more likely, guarantee a conformation of the 
cytoplasmic tail that favors higher  order assembly. The as- 
sociation of p63 into large complexes could prevent p63 mol- 
ecules from entering  budding vesicles and thereby provide 
a mechanism for retention.  Alternatively,  failure of the mu- 
tant  p63  molecules to  form the  higher  order  complexes 
would result in leakage of the molecules out of the compart- 
ment with eventual  delivery to the cell surface.  This pro- 
posed model for the localization  of p63 involves a retention 
rather than a retrieval mechanism, which is compatible with 
previous data suggesting that p63 is a stably anchored resi- 
dent protein. 
Oligomerization  has  also been suggested  as a  retention 
mechanism for proteins in the Golgi apparatus  (Machamer 
1991; Nilsson et al.,  1991, 1993, 1994; Swift and Macha- 
mer,  1991). The only example  where retention  in this or- 
ganelle has actually been correlated with oligomerization  is 
a chimeric membrane protein in which the membrane-span- 
ning domain of VSV G protein was replaced with the first 
membrane-spanning  domain of the M glycoprotein  of avian 
coronavirus (Weisz et al., 1993). However, in contrast to the 
chimera, oligomerization  of the intact M glycoprotein could 
not be demonstrated.  Recently, Nilsson et al.  (1993, 1994) 
have proposed a model whereby Golgi enzymes form homo- 
dimers in which the lumenal domains  are bound together 
while the transmembrane  domains  interact  with those of 
identical or related enzymes of the same Golgi cisternae to 
form hetero-oligomers.  The cytoplasmic domains would be 
attached to an underlying  matrix  to stabilize  larger  arrays. 
Although  similar  in  the  overall  architecture,  this  Golgi 
model differs from the model supported by the p63 data in 
several ways. In particular,  the domains responsible for the 
formation of higher order structures (cytoplasmic tail versus 
transmembrane domain)  and the kind of oligomers formed 
(homo-  versus  hetero-oligomers)  are  distinct.  Taken  to- 
gether, oligomerization  is likely to be a general mechanism 
that specifies location of proteins in different compartments 
of the secretory pathway. Oligomerization  per se, however, 
seems to be achievable by different mechanisms  and forms 
of interactions. 
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